We investigate the superfluid (SF) to Bose-glass (BG) quantum phase transition using extensive quantum Monte Carlo simulations of two-dimensional hard-core bosons in a random box potential. T=0 critical properties are studied by thorough finite-size scaling of condensate and SF densities, both vanishing at the same critical disorder Wc=4.80(5). Our results give the following estimates for the critical exponents: z=1.85(15), ν=1.20(12), η=-0.40(15). Furthermore, the probability distribution of the SF response P(lnρSF) displays striking differences across the transition: while it narrows with increasing system sizes L in the SF phase, it broadens in the BG regime, indicating an absence of self-averaging, and at the critical point P(lnρSF+zlnL) is scale invariant. Finally, high-precision measurements of the local density rule out a percolation picture for the SF-BG transition.
A spin-wave approach of the zero temperature superfluid-insulator transition for two-dimensional hard-core bosons in a random potential μ=±W is developed. While at the classical level there is no intervening phase between the Bose-condensed superfluid (SF) and the gapped disordered insulator, the introduction of quantum fluctuations leads to a much richer physics. Upon increasing the disorder strength W, the Bose-condensed fraction disappears first, before the SF. Then a gapless Bose-glass phase emerges over a finite region until the insulator appears. Furthermore, in the strongly disordered SF regime, a mobility edge in the spin-wave excitation spectrum is found at a finite frequency Ω(c) decreasing with W, and presumably vanishing in the Bose-glass phase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.